WHO Launches Ebola Treatment Trial in DRC Amid Outbreak
The World Health Organization (WHO) announced a trial for two antiviral drugs aimed at treating Ebola in the Democratic Republic of Congo (DRC). The trial was launched by WHO Director-General Tedros Adhanom Ghebreyesus and DRC's Health Minister Dr. Samuel Roger Kamba.
The current outbreak of Ebola in DRC began in May, with the situation declared a public health emergency due to the virus's high infectivity and the absence of approved vaccines or treatments. As of July 1, there have been confirmed cases and deaths, including two fatalities in Uganda linked to the outbreak.
The trial is being coordinated by scientists from the Institut National de Recherche Biomédicale in DRC, the Institut Tropical de Médecine in Belgium, and the University of Oxford in the UK. The outbreak is currently restricted to three eastern provinces: South Kivu, North Kivu, and Ituri.
Plus234Feed summary based on reporting from Voice of Nigeria. Read the original report below.
Read full article
Continue on Voice of Nigeria
Get the week in one email
Top stories, NPFL results, the naira — every Friday morning. Free, one email a week.
Related Stories
WHO Launches Vaccine Trial Amid Ebola Outbreak in DRC
DR Congo Launches New Ebola Treatment Center in Beni
First Ebola Recovery Confirmed in DRC Outbreak
WHO Warns Ebola Outbreak Surpassing Response Efforts
WHO: DRC Ebola Response Underfunded, Urgent Support Needed
WHO Declares Highest Ebola Risk Level in DRC
Get Plus234Feed on messaging apps
Same headlines, delivered where you already scroll.
